General Information of the Protein
Protein ID
PT00907
Protein Name
Dipeptidyl peptidase 4
Secondarily
Protein Name
ADABP
Adenosine deaminase complexing protein 2
Dipeptidyl peptidase IV
T-cell activation antigen CD26
TP103
Dipeptidyl peptidase IV membrane form
Dipeptidyl peptidase IV soluble form
Gene Name
DPP4
Secondarily
Gene Name
ADCP2
CD26
Sequence
MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Serine protease
>
Serine protease SC clan
>
Serine protease S9B subfamily
Function
Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation (PubMed:10951221, PubMed:10900005, PubMed:11772392, PubMed:17287217). Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC (PubMed:10951221, PubMed:10900005, PubMed:11772392, PubMed:14691230). Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner (PubMed:17287217). Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion (PubMed:11772392). In association with FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM (PubMed:16651416, PubMed:10593948). May be involved in the promotion of lymphatic endothelial cells adhesion, migration and tube formation (PubMed:18708048). When overexpressed, enhanced cell proliferation, a process inhibited by GPC3 (PubMed:17549790). Acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones such as brain natriuretic peptide 32 (PubMed:16254193, PubMed:10570924). Removes N-terminal dipeptides sequentially from polypeptides having unsubstituted N-termini provided that the penultimate residue is proline (PubMed:10593948).
    Show/Hide
Uniprot ID
Primary ID:
P27487

Secondarily ID:
Q53TN1
    Show/Hide
Ensembl ID
ENSG00000197635
HGNC ID
HGNC:3009
Subcellular Location
Secreted
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000023 , BTI-Tn-5B1-4
Compound ID Compound Name Compound Formula
CP0377209
(S)-1-((S)-2-amino-5-(1-oxoisoindolin-2-yl)pentanoyl)pyrrolidine-2-carbonitrile
   Show/Hide
C18H22N4O2
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0007316
(1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorobenzyl)propylamine
   Show/Hide
C16H15F6N5O
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0048107
(2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
   Show/Hide
C17H25N3O2
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0417860
(2R)-1-{(2S, 4S)-4-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}pyrrolidine-2-boronic Acid
   Show/Hide
C19H24BN3O5
 1
1
IC50 = 570 nM
   TI
   LI
   LO
   TS
CP0172402
(R)-1-(2-(1-oxoisoindolin-2-yl)acetyl)pyrrolidin-2-ylboronic acid
   Show/Hide
C14H17BN2O4
 1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS
CP0067540
(R)-1-(2-(1-naphthamido)acetyl)pyrrolidin-2-ylboronic acid
   Show/Hide
C17H19BN2O4
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0077736
(2S)-1-[(2S)-2-amino-4-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-4-oxobutanoyl]pyrrolidine-2-carbonitrile
   Show/Hide
C26H29F2N5O2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0089998
(2S)-1-({(2S,4S)-4-[2-(1,3-Dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)-4,4-difluoropyrrolidine-2-carbonitrile
   Show/Hide
C20H20F2N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0117955
(S)-N-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)-1-naphthamide
   Show/Hide
C18H17N3O2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0138655
(2S,3R)-2-amino-1-(isoindolin-2-yl)-3-methylpentan-1-one
   Show/Hide
C14H20N2O
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0280292
2-(S)-Amino-4-(2-chloro-benzylamino)-1-piperidin-1-yl-butan-1-one
   Show/Hide
C16H24ClN3O
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0365775
(2S,4S)-1-({(2S,4S)-4-[2-(1,3-Dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)-4-fluoropyrrolidine-2-carbonitrile
   Show/Hide
C20H21FN4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0377210
(S)-1-((2S,4R)-4-(2-(isoindolin-2-yl)-2-oxoethyl)-5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C20H22N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0377211
(2S)-1-[{(2S,4S)-5-Oxo-4-(2-oxo-2-(piperidin-1-yl)ethyl)pyrrolidine-2-yl}carbonyl]pyrrolidine-2-carbonitrile
   Show/Hide
C17H24N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0377217
(2S)-1-{(2S,4S)-4-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}pyrrolidine-2-carboxylic Acid tert-Butylamide
   Show/Hide
C24H32N4O4
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0377219
(2S)-1-({(2S,4S)-4-[2-[4-(Pyridine-4-yl)-piperazin-1-yl]-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C21H26N6O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0386927
(2S)-1-{(2S,4S)-4-[2-(5-Fluoro-1,3-dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}pyrrolidine-2-carbonitrile
   Show/Hide
C20H21FN4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0386928
(2S)-1-({(2S,4S)-4-[2-[4-(4-Chlorophenyl)-3,6-dihydropyridin-1(2H)-yl]-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C23H25ClN4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0398656
(2S)-1-({(2S,4S)-4-[2-(5-Chloro-1,3-dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C20H21ClN4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0398665
(2S)-1-({(2S,4S)-4-[2-(1,3-Dihydro-2H-isoquinol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C21H24N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0405590
(3S,5S)-3-[2-(1,3-Dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-2-one
   Show/Hide
C18H21N3O3S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0405591
(3S,5S)-3-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-(pyrrolidine-1-carbonyl)pyrrolidin-2-one
   Show/Hide
C19H23N3O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0405592
(2S)-1-({(2S,4S)-4-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}pyrrolidine-2-carboxylic Acid Amide
   Show/Hide
C20H24N4O4
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0405593
(2S)-1-{(2S, 4S)-4-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}pyrrolidine-2-carbonitrile
   Show/Hide
C20H22N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0416406
(2S)-1-({(2S,4S)-5-Oxo-4-[2-oxo-2-(pyrrolidin-1-yl)ethyl]pyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C16H22N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0416420
2S)-1-({(2S,4S)-5-oxo-4-[2-Oxo-[2-(trifluoromethyl)-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]ethyl]pyrrolidin-2-yl}carbonyl)-pyrrolidine-2-carbonitrile
   Show/Hide
C19H21F3N6O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0417856
(2S)-1-({(2S,4S)-5-Oxo-4-[2-oxo-2-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]ethyl]pyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C18H20F3N7O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0417859
(2S,4S)-1-{(2S,4S)-4-[2-(5-Chloro-1,3-dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl}-4-fluoropyrrolidine-2-carbonitrile
   Show/Hide
C20H20ClFN4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0469898
2-[(3S,5S)-5-{[(2S)-2-Cyanopyrrolidin-1-yl]carbonyl}-2-oxopyrrolidin-3-yl]-N-phenylacetamide
   Show/Hide
C18H20N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0473229
2S)-1-({(2S,4S)-4-[2-(6,7-Dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C19H22N4O3S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0477589
(2S)-1-({(2S,4S)-4-[2-(5-Trifluoromethyl-1,3-dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C21H21F3N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0507612
(2S)-1-({(2S,4S)-4-[2-[4-(4-Fluorophenyl)piperazin-1-yl]-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C22H26FN5O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0903652
(2S)-1-((2S)-4-(2-(isoindolin-2-yl)-2-oxoethyl)-5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile
   Show/Hide
C20H22N4O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0075223
8-((R)-3-amino-piperidin-1-yl)-3-methyl-7-(3-methyl-but-2-enyl)-1-(2-oxo-2-phenyl-ethyl)-3,7-dihydro-purine-2,6-dione
   Show/Hide
C24H30N6O3
 3
1 Activity = 1 nM
2 IC50 = 1 nM
3 IC50 = 1.1 nM
CP0059084
8-((S)-3-amino-piperidin-1-yl)-3-methyl-7-(3-methyl-but-2-enyl)-1-(2-oxo-2-phenyl-ethyl)-3,7-dihydro-purine-2,6-dione
   Show/Hide
C24H30N6O3
 4
1 Activity = 2 nM
2 IC50 = 5 nM
3 Kd = 0.42 nM
4 Kd = 9.2 nM
CP0305354
1,3-dimethyl-7-(3-methylbut-2-enyl)-8-(piperazin-1-yl)-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C16H24N6O2
 1
1 Activity = 117 nM
CP0079344
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C25H28N8O2
 6
1 IC50 = 0.1 nM
2 IC50 = 0.4 nM
3 IC50 = 1 nM
4 IC50 = 1.25 nM
5 IC50 = 2 nM
6 Kd = 5.3 nM
CP0048107
(2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile
   Show/Hide
C17H25N3O2
 18
1 IC50 = 0.58 nM
2 IC50 = 3 nM
3 IC50 = 9 nM
4 IC50 = 10 nM
5 IC50 = 16 nM
6 IC50 = 16.6 nM
7 IC50 = 17 nM
8 IC50 = 23 nM
9 IC50 = 34 nM
10 IC50 = 51 nM
11 IC50 = 56 nM
12 IC50 = 95 nM
13 IC50 = 120 nM
14 IC50 = 3500 nM
15 Kd = 2.4 nM
16 Kd = 10.7 nM
17 Ki = 3 nM
18 Ki = 17000 nM
CP0039344
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid
   Show/Hide
C18H25N3O2
 10
1 IC50 = 0.6 nM
2 IC50 = 1.5 nM
3 IC50 = 3 nM
4 IC50 = 3.37 nM
5 IC50 = 3.4 nM
6 IC50 = 30.3 nM
7 IC50 = 50 nM
8 Kd = 0.3 nM
9 Kd = 15.9 nM
10 Ki = 0.6 nM
CP0139059
(R)-1-((S)-2-aminopropanoyl)pyrrolidin-2-ylboronic acid
   Show/Hide
C7H15BN2O3
 4
1 IC50 = 1 nM
2 IC50 = 15 nM
3 IC50 = 1600 nM
4 Ki = 2 nM
CP0053608
2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)benzonitrile
   Show/Hide
C18H21N5O2
 13
1 IC50 = 1 nM
2 IC50 = 1.5 nM
3 IC50 = 3.1 nM
4 IC50 = 3.4 nM
5 IC50 = 4 nM
6 IC50 = 5.3 nM
7 IC50 = 6.9 nM
8 IC50 = 7 nM
9 IC50 = 7.5 nM
10 IC50 = 7.6 nM
11 IC50 < 10 nM
12 Kd = 2.4 nM
13 Kd = 28.5 nM
CP0285875
(R)-2-(2-(2-(8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3-dihydro-6H-purin-1(7H)-yl)acetyl)phenoxy)-N-methylacetamide
   Show/Hide
C26H31N7O5
 1
1 IC50 = 1 nM
CP0059208
(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine
   Show/Hide
C16H18F2N4O
 1
1 IC50 = 1.4 nM
CP0064961
MK-3102
   Show/Hide
C17H20F2N4O3S
 4
1 IC50 = 1.6 nM
2 IC50 = 3.1 nM
3 Kd = 2.75 nM
4 Ki = 0.8 nM
CP0716729
US8592371, 3
   Show/Hide
C21H26F2N4O3S
 1
1 IC50 = 2.6 nM
CP0053807
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((3-methylisoquinolin-1-yl)methyl)-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C26H29N7O2
 1
1 IC50 = 3 nM
CP0007316
(1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorobenzyl)propylamine
   Show/Hide
C16H15F6N5O
 23
1 IC50 = 3.5 nM
2 IC50 = 7 nM
3 IC50 = 7.8 nM
4 IC50 = 8.4 nM
5 IC50 = 8.8 nM
6 IC50 = 10 nM
7 IC50 = 12 nM
8 IC50 = 16 nM
9 IC50 = 17 nM
10 IC50 = 18 nM
11 IC50 = 19 nM
12 IC50 = 19.4 nM
13 IC50 = 20 nM
14 IC50 = 22 nM
15 IC50 = 24.83 nM
16 IC50 = 29 nM
17 IC50 = 30 nM
18 IC50 = 40 nM
19 IC50 = 46 nM
20 IC50 = 120 nM
21 Kd = 5.3 nM
22 Kd = 12.7 nM
23 Kd = 13.5 nM
CP0645535
(2S,3S)-3-amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]pyridin-6-ylphenyl)butanamide trifluoroacetate
   Show/Hide
C24H26F4N6O4
 2
1 IC50 = 4.3 nM
2 IC50 = 44 nM
CP0052765
8-(3-Amino-piperidin-1-yl)-3-methyl-7-(3-methyl-but-2-enyl)-1-(2-oxo-2-phenyl-ethyl)-3,7-dihydro-purine-2,6-dione
   Show/Hide
C24H30N6O3
 1
1 IC50 = 5 nM
CP0660053
Trifluoro-acetate(1S,2S)-2-dimethylcarbamoyl-2-(4'-fluoro-biphenyl-4-yl)-1-((S)-3-fluoro-pyrrolidine-1-carbonyl)-ethyl-ammonium
   Show/Hide
C24H26F5N3O4
 6
1 IC50 = 12 nM
2 IC50 = 18 nM
3 IC50 = 39 nM
4 IC50 = 376 nM
5 IC50 = 387 nM
6 IC50 = 390 nM
CP0699956
(2S,3S)-1-((S)-3-fluoropyrrolidin-1-yl)-3-(4-(N-methylacetamido)cyclohexyl)-1-oxobutan-2-aminium chloride
   Show/Hide
C17H31ClFN3O2
 1
1 IC50 = 40 nM
CP0703918
(2S,3S)-1-((S)-3-fluoropyrrolidin-1-yl)-3-(4-(N-methylcyclopropanecarboxamido)cyclohexyl)-1-oxobutan-2-aminium chloride
   Show/Hide
C19H33ClFN3O2
 1
1 IC50 = 47 nM
CP0802309
(R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate
   Show/Hide
C16H18F6N5O5P
 2
1 IC50 = 50 nM
2 IC50 = 87 nM
CP0648753
Trifluoro-acetate(1S,2S)-2-(4'-fluoro-biphenyl-4-yl)-1-((S)-3-fluoro-pyrrolidine-1-carbonyl)-propyl-ammonium
   Show/Hide
C22H23F5N2O3
 1
1 IC50 = 64 nM
CP0239964
8-(3-aminopiperidin-1-yl)-7-benzyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C19H24N6O2
 3
1 IC50 = 82 nM
2 Kd = 13.2 nM
3 Kd = 18.6 nM
CP0703919
(2S,3S)-3-(4-(3-fluoro-N-methylbenzamido)cyclohexyl)-1-((S)-3-fluoropyrrolidin-1-yl)-1-oxobutan-2-aminium chloride
   Show/Hide
C22H32ClF2N3O2
 1
1 IC50 = 92 nM
CP0709548
(2S,3S)-1-((S)-3-fluoropyrrolidin-1-yl)-3-(4-(4-methoxy-N-methylbenzamido)cyclohexyl)-1-oxobutan-2-aminium chloride
   Show/Hide
C23H35ClFN3O3
 1
1 IC50 = 97 nM
CP0155216
(2R,3S)-3-(2,4,5-trifluorophenyl)-2,3-dihydro-1H-benzo[f]chromen-2-amine
   Show/Hide
C19H14F3NO
 1
1 IC50 = 110.1 nM
CP0293093
6-(2-(2-(5-cyano-4,5-dihydro-1H-pyrazol-1-yl)-2-oxoethylamino)ethylamino)nicotinonitrile
   Show/Hide
C14H15N7O
 1
1 IC50 = 140 nM
CP0294704
(8R,9S)-9-amino-4-methyl-8-(2,4,5-trifluorophenyl)-9,10-dihydro-8H-pyrano[2,3-h]chromen-2-one
   Show/Hide
C19H14F3NO3
 1
1 IC50 = 154.67 nM
CP0660057
trifluoro-acetate(1S,2S)-2-dimethylcarbamoyl-2-{4-[(4-fluoro-benzoyl)-methyl-amino]-phenyl}-1-((S)-3-fluoro-pyrrolidine-1-carbonyl)-ethyl-ammonium
   Show/Hide
C26H29F5N4O5
 1
1 IC50 = 160 nM
CP0733246
(2S,3S)-4-(dimethylamino)-1-((S)-3-fluoropyrrolidin-1-yl)-3-(4-(N-methylacetamido)cyclohexyl)-1,4-dioxobutan-2-aminium chloride
   Show/Hide
C19H34ClFN4O3
 1
1 IC50 = 190 nM
CP0284910
(R)-3-Amino-N-(1,1-dioxo-4-thiazol-2-yl-hexahydro-1lambda*6*-thiopyran-4-yl)-4-(2-fluoro-phenyl)-butyramide
   Show/Hide
C18H22FN3O3S2
 1
1 IC50 = 190 nM
CP0724305
(2S,3S)-4-(dimethylamino)-3-(4-(3-fluoro-N-methylbenzamido)cyclohexyl)-1-((S)-3-fluoropyrrolidin-1-yl)-1,4-dioxobutan-2-aminium chloride
   Show/Hide
C24H35ClF2N4O3
 1
1 IC50 = 200 nM
CP0709553
(2S,3S)-1-((S)-3-fluoropyrrolidin-1-yl)-3-(4-(4-methoxybenzamido)cyclohexyl)-1-oxobutan-2-aminium chloride
   Show/Hide
C22H33ClFN3O3
 1
1 IC50 = 210 nM
CP0077736
(2S)-1-[(2S)-2-amino-4-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-4-oxobutanoyl]pyrrolidine-2-carbonitrile
   Show/Hide
C26H29F2N5O2
 2
1 IC50 = 227 nM
2 IC50 = 274 nM
CP0789384
(2S,3S)-3-(4-(2,4-difluorophenylsulfonamido)cyclohexyl)-4-(dimethylamino)-1-((S)-3-fluoropyrrolidin-1-yl)-1,4-dioxobutan-2-aminium chloride
   Show/Hide
C22H32ClF3N4O4S
 1
1 IC50 = 510 nM
CP0252609
(R)-3-Amino-N-(1,1-dioxo-4-phenyl-hexahydro-1lambda*6*-thiopyran-4-yl)-4-(2-fluoro-phenyl)-butyramide
   Show/Hide
C21H25FN2O3S
 1
1 IC50 = 570 nM
CP0704352
(2S,3S)-4-(dimethylamino)-1-((S)-3-fluoropyrrolidin-1-yl)-1,4-dioxo-3-(4-(4-(trifluoromethoxy)phenylsulfonamido)cyclohexyl)butan-2-aminium chloride
   Show/Hide
C23H33ClF4N4O5S
 1
1 IC50 = 1280 nM
CP0686265
(2S,3S)-3-(4-(2,4-difluorophenylsulfonamido)cyclohexyl)-1-((S)-3-fluoropyrrolidin-1-yl)-1-oxobutan-2-aminium chloride
   Show/Hide
C20H29ClF3N3O3S
 1
1 IC50 = 1490 nM
CP0704351
(2S,3S)-1-((S)-3-fluoropyrrolidin-1-yl)-1-oxo-3-(4-(4-(trifluoromethoxy)phenylsulfonamido)cyclohexyl)butan-2-aminium chloride
   Show/Hide
C21H30ClF4N3O4S
 1
1 IC50 = 3470 nM
CP0138655
(2S,3R)-2-amino-1-(isoindolin-2-yl)-3-methylpentan-1-one
   Show/Hide
C14H20N2O
 1
1 IC50 = 90000 nM
CP0365775
(2S,4S)-1-({(2S,4S)-4-[2-(1,3-Dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)-4-fluoropyrrolidine-2-carbonitrile
   Show/Hide
C20H21FN4O3
 1
1 IC50 > 50000 nM
CP0117955
(S)-N-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)-1-naphthamide
   Show/Hide
C18H17N3O2
 1
1 IC50 > 100000 nM
CP0067540
(R)-1-(2-(1-naphthamido)acetyl)pyrrolidin-2-ylboronic acid
   Show/Hide
C17H19BN2O4
 1
1 IC50 > 100000 nM
CP0042682
N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide
   Show/Hide
C17H16N4O2
 1
1 IC50 > 100000 nM
CP0086238
N-[2-[(2S)-2-cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide
   Show/Hide
C17H14F2N4O2
 1
1 IC50 > 100000 nM
CP0089998
(2S)-1-({(2S,4S)-4-[2-(1,3-Dihydro-2H-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)-4,4-difluoropyrrolidine-2-carbonitrile
   Show/Hide
C20H20F2N4O3
 1
1 IC50 > 100000 nM
CP0115201
(2S,3R)-8,9-dimethoxy-3-(2,4,5-trifluorophenyl)-2,3-dihydro-1H-benzo[f]chromen-2-amine
   Show/Hide
C21H18F3NO3
 1
1 Kd = 2.38 nM
CP0179695
(2S,3R)-9-methoxy-8-methylsulfonyl-3-(2,4,5-trifluorophenyl)-2,3-dihydro-1H-benzo[f]chromen-2-amine
   Show/Hide
C21H18F3NO4S
 1
1 Kd = 11 nM
CP0214060
(2S)-1-[(2S)-2-amino-2-cyclopentylacetyl]pyrrolidine-2-carbonitrile
   Show/Hide
C12H19N3O
 1
1 Ki = 1.1 nM
CP0172402
(R)-1-(2-(1-oxoisoindolin-2-yl)acetyl)pyrrolidin-2-ylboronic acid
   Show/Hide
C14H17BN2O4
 1
1 Ki = 22700 nM
Clinical Information about the Protein
Target 1 ( Dipeptidyl peptidase 4 (DPP-4) )
Target Type Successful Target
Disease 4 Target-related Diseases  4
1 Type-2 diabetes [ICD-11: 5A11]
2 Diabetic complication [ICD-11: 5A2Y]
3 Non-insulin dependent diabetes [ICD-11: 5A11]
4 Metabolic disorder [ICD-11: 5C50-5D2Z]
Approved Drug(s) 6 Approved Drugs  6
1 Alogliptin Approved
Type-2 diabetes
2 Anagliptin Approved
Type-2 diabetes
3 Linagliptin Approved
Type-2 diabetes
4 Saxagliptin Approved
Type-2 diabetes
5 Vildagliptin Approved
Type-2 diabetes
6 Sitagliptin Approved
Type-2 diabetes
Clinical Trial Drug(s) 6 Clinical Trial Drugs  6
1 Dutogliptin Phase 3
Type-2 diabetes
2 MK-3102 Phase 3
Type-2 diabetes
3 PF-00734200 Phase 2
Type-2 diabetes
4 DA-1229 Phase 1
Type-2 diabetes
5 Teneligliptin Phase 1
Type-2 diabetes
6 SYR-472 Phase 3
Metabolic disorder
Discontinued Drug(s) 4 Discontinued Drugs  4
1 NVP-DPP728 Discontinued in Phase 2
Type-2 diabetes
2 ABT-279 Discontinued in Phase 1
Type-2 diabetes
3 TAK-100 Discontinued in Phase 1
Diabetic complication
4 PT-630 Terminated
Type-2 diabetes
Investigative Drug(s) 1 Investigative Drug  1
1 KR-62436 Investigative
Non-insulin dependent diabetes
Target 2 ( HUMAN dipeptidyl peptidase 4 (DPP-4) )
Target Type Unknown Type Target
Disease 1 Target-related Disease  1
1 Type 2 diabetes [ICD-11: 5A11]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 Linagliptin Approved
Type 2 diabetes